✦ LIBER ✦

850 EARLY VIROLOGIC RESPONSE (EVR) IN TREATMENT-NAÏVE MONO-INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH CEPEGINTERFERON-alfa-2b (cePEG-IFNa-2b) PLUS RIBAVIRIN

✍ Scribed by Znoyko, O.; Maevskaya, M.; Klimova, E.; Kizhlo, S.; Petrochenkova, N.; Maximov, S.; Nagimova, F.; Ivanov, R.; Linkova, Y.; Chernovskaya, T.

Book ID: 123582478
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 78 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60852-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early virologic response to treatment wi

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

✍ Gary L. Davis; John B. Wong; John G. McHutchison; Michael P. Manns; Joann Harvey 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Predictors of Sustained Virologic Respon

Predictors of Sustained Virologic Response Among Treatment-NaïVE Patients With Hepatitis C Virus Genotype 1 When Treated With Boceprevir (Boc) Plus Peginterferon Alfa-2B-Ribavirin (PR)

✍ Reddy, Rajender ;Bruno, Savino ;Rossaro, Lorenzo ;Ravendhran, Natarajan ;Pauly, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Early virologic response and IL28B polym

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

✍ Thomas-Matthias Scherzer; Harald Hofer; Albert Friedrich Staettermayer; Karoline 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 801 KB

[573] COMPARISON OF EARLY VIROLOGIC RESP

[573] COMPARISON OF EARLY VIROLOGIC RESPONSE AMONG PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE NON 2/3 TREATED WITH PEGYLATED INTERFERON ALFA-2b AND RIBAVIRIN IN DEPENDENCE WITH HEPATIC FIBROSIS STAGES

✍ H. Berak; A. Kolakowska-Rzadzka; M. Wasilewski; J. Kowalska; I. Stanczak; K. Bar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Pegylated interferon alpha-2b (Peg-IFN α

Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

✍ T. Oze; N. Hiramatsu; T. Yakushijin; M. Kurokawa; T. Igura; K. Mochizuki; K. Ima 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB